Breast Cancer Research and Treatment

Title Publication Date Language Citations
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients2009/12/18English2,030
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis2010/06/23English660
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer2010/08/28English610
Epidemiology of basal-like breast cancer2007/06/20English591
REporting recommendations for tumor MARKer prognostic studies (REMARK)2006/08/24English588
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses2008/01/11English545
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients2016/10/15English531
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study2017/10/23English490
Role of epidermal growth factor receptor in breast cancer2012/10/17English458
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review2012/06/12English454
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer2014/05/20English401
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study2007/02/27English383
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen2006/11/18English381
Pattern of metastatic spread in triple-negative breast cancer2008/06/10English377
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry2013/05/16English357
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer2010/08/21English350
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer2007/05/03English335
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer2005/09/15English329
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine2009/11/07English306
An overview of prognostic factors for long-term survivors of breast cancer2007/03/22English300
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro2007/02/01English291
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer2016/11/25English283
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA2008/03/07English278
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review2018/02/07English274
MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research2006/09/27English271
Physical activity and risk of breast cancer: a meta-analysis of prospective studies2012/12/30English270
Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases2011/06/17English267
Significance of interleukin-6 (IL-6) in breast cancer (review)2006/08/23English266
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype2011/12/07English261
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy2006/09/29English258